Notice Information
Notice Title
Cytokine Modulators
Notice Description
The Framework Agreement is for the supply and delivery of the following Anti-TNF agents and associated dual therapy medicines to health boards across NHS Scotland: Etanercept Infliximab Methotrexate The Goods have been split into five (5) categories, each of which are identified as a "Lot". Full details of each Lots are contained in section II.2 of this notice.
Lot Information
Etanercept
This Lot is for the supply of Etanercept 10mg, 25mg, 50mg presentations to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. Each product line has been treated as an individual Lot and is awarded on a line by line basis. This Lot was awarded as an unranked multi supplier Framework to three (3) suppliers.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
InfliximabThis Lot is for the supply Infliximab 100mg powder for concentrate for solution for infusion to NHS Scotland. This Lot has been awarded as an unranked multi supplier Framework and awarded to five (5) suppliers.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection deviceThis Lot is for the supply of Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. The Authority has awarded as an unranked multi-supplier Framework Agreement for the Lot to two (2) suppliers.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement of up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Methotrexate (25 mg per 1 ml concentration ) pre-filled syringesThis Lot is for the supply of Methotrexate (25 mg per 1 ml concentration ) pre-filled syringes to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. The Authority has awarded a an unranked multi-supplier Framework Agreement for the Lot and to one (1) supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement of up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection deviceThis Lot is for the supply of Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. The Authority has awarded a an unranked multi-supplier Framework Agreement for the Lot and to one (1) supplier.
Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement of up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-r6ebe6-0000557325
- Publication Source
- Public Contracts Scotland
- Latest Notice
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=DEC340063
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- OJEU - F3 - Contract Award Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £107,012,831 £100M-£1B
- Lots Value
- £106,967,156 £100M-£1B
- Awards Value
- Not specified
- Contracts Value
- £89,735,964 £10M-£100M
Notice Dates
- Publication Date
- 13 Dec 20187 years ago
- Submission Deadline
- 24 Oct 2018Expired
- Future Notice Date
- Not specified
- Award Date
- 19 Nov 20187 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Complete
- Awards Status
- Not Specified
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")
- Contact Name
- Linda Downie, Siobhan Ramage
- Contact Email
- l.downie@nhs.net, siobhan.ramage@nhs.net
- Contact Phone
- +44 1698794410
Buyer Location
- Locality
- EDINBURGH
- Postcode
- EH12 9EB
- Post Town
- Edinburgh
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM1 East Central Scotland
- Small Region (ITL 3)
- TLM13 City of Edinburgh
- Delivery Location
- TLM Scotland
-
- Local Authority
- City of Edinburgh
- Electoral Ward
- Drum Brae/Gyle
- Westminster Constituency
- Edinburgh South West
Further Information
Notice Documents
-
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP332008
Cytokine Modulators - The Framework Agreement is for the supply and delivery of the following Anti-TNF agents and associated dual therapy medicines to health boards across NHS Scotland: Etanercept Infliximab Methotrexate The Goods have been split into five (5) categories, each of which are identified as a "Lot". Full details of each Lot are contained in section II.2 of this notice. -
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=DEC340063
Cytokine Modulators - The Framework Agreement is for the supply and delivery of the following Anti-TNF agents and associated dual therapy medicines to health boards across NHS Scotland: Etanercept Infliximab Methotrexate The Goods have been split into five (5) categories, each of which are identified as a "Lot". Full details of each Lots are contained in section II.2 of this notice.
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-r6ebe6-0000557325-2018-12-13T00:00:00Z",
"date": "2018-12-13T00:00:00Z",
"ocid": "ocds-r6ebe6-0000557325",
"initiationType": "tender",
"parties": [
{
"id": "org-16",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB"
},
"contactPoint": {
"name": "Linda Downie",
"email": "l.downie@nhs.net",
"telephone": "+44 1698794410",
"url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html"
},
"roles": [
"buyer",
"centralPurchasingBody",
"reviewBody"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
}
],
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
},
{
"id": "org-3",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB"
},
"contactPoint": {
"name": "Siobhan Ramage",
"email": "siobhan.ramage@nhs.net",
"telephone": "+44 1698794410",
"url": "http://"
},
"roles": [
"buyer"
],
"details": {
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
},
{
"id": "org-37",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB"
},
"contactPoint": {
"name": "Siobhan Ramage",
"email": "siobhan.ramage@nhs.net",
"telephone": "+44 1698794410",
"url": "http://"
},
"roles": [
"buyer",
"centralPurchasingBody",
"reviewBody"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
}
],
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
},
{
"id": "org-183",
"name": "Biogen Idec Ltd.",
"identifier": {
"legalName": "Biogen Idec Ltd."
},
"address": {
"streetAddress": "Innovation House, 70 Norden Road",
"locality": "Maidenhead",
"region": "UKM",
"postalCode": "SL4 6AY"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-184",
"name": "Pfizer Ltd",
"identifier": {
"legalName": "Pfizer Ltd"
},
"address": {
"streetAddress": "Walton Oaks, Dorking Road, Surrey",
"locality": "Tadworth",
"region": "UKM",
"postalCode": "KT20 7NS"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-185",
"name": "Sandoz Ltd",
"identifier": {
"legalName": "Sandoz Ltd"
},
"address": {
"streetAddress": "Frimley Business Park, Frimley",
"locality": "Camberley",
"region": "UKM",
"postalCode": "GU16 7SR"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-186",
"name": "Napp Pharmaceuticals",
"identifier": {
"legalName": "Napp Pharmaceuticals"
},
"address": {
"streetAddress": "Milton Road , Science Park",
"locality": "Cambridge",
"region": "UKM",
"postalCode": "CB4 0AB"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-187",
"name": "MSD",
"identifier": {
"legalName": "MSD"
},
"address": {
"streetAddress": "HERTFORD ROAD",
"locality": "HODDESDON",
"region": "UKM",
"postalCode": "EN11 9BU"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-188",
"name": "Accord Healthcare Ltd",
"identifier": {
"legalName": "Accord Healthcare Ltd"
},
"address": {
"streetAddress": "Sage House, 319 Piner Road",
"locality": "North Harrow",
"region": "UKM",
"postalCode": "HA1 4HF"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-189",
"name": "medac Pharma LLP",
"identifier": {
"legalName": "medac Pharma LLP"
},
"address": {
"streetAddress": "Scion House, Innovation Park",
"locality": "Stirling",
"region": "UKM",
"postalCode": "FK9 4NF"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-190",
"name": "Nordic Pharma Ltd",
"identifier": {
"legalName": "Nordic Pharma Ltd"
},
"address": {
"streetAddress": "Unit 3, Commerce Park, Brunel Road",
"locality": "Theale",
"region": "UKM",
"postalCode": "RG7 4AB"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
}
],
"buyer": {
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"id": "org-37"
},
"tender": {
"id": "NP47918",
"title": "Cytokine Modulators",
"description": "The Framework Agreement is for the supply and delivery of the following Anti-TNF agents and associated dual therapy medicines to health boards across NHS Scotland: Etanercept Infliximab Methotrexate The Goods have been split into five (5) categories, each of which are identified as a \"Lot\". Full details of each Lots are contained in section II.2 of this notice.",
"status": "complete",
"items": [
{
"id": "1",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "1"
},
{
"id": "2",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "2"
},
{
"id": "3",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014"
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "3"
},
{
"id": "4",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014"
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "4"
},
{
"id": "5",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "5"
}
],
"value": {
"amount": 107012831,
"currency": "GBP"
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"mainProcurementCategory": "goods",
"submissionMethod": [
"electronicSubmission"
],
"submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
"tenderPeriod": {
"endDate": "2018-10-24T12:00:00Z"
},
"awardPeriod": {
"startDate": "2018-10-24T12:00:00Z"
},
"documents": [
{
"id": "SEP332008",
"documentType": "contractNotice",
"title": "Cytokine Modulators",
"description": "The Framework Agreement is for the supply and delivery of the following Anti-TNF agents and associated dual therapy medicines to health boards across NHS Scotland: Etanercept Infliximab Methotrexate The Goods have been split into five (5) categories, each of which are identified as a \"Lot\". Full details of each Lot are contained in section II.2 of this notice.",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP332008",
"format": "text/html"
},
{
"id": "DEC340063",
"documentType": "awardNotice",
"title": "Cytokine Modulators",
"description": "The Framework Agreement is for the supply and delivery of the following Anti-TNF agents and associated dual therapy medicines to health boards across NHS Scotland: Etanercept Infliximab Methotrexate The Goods have been split into five (5) categories, each of which are identified as a \"Lot\". Full details of each Lots are contained in section II.2 of this notice.",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=DEC340063",
"format": "text/html"
}
],
"lots": [
{
"id": "1",
"title": "Etanercept",
"description": "This Lot is for the supply of Etanercept 10mg, 25mg, 50mg presentations to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. Each product line has been treated as an individual Lot and is awarded on a line by line basis. This Lot was awarded as an unranked multi supplier Framework to three (3) suppliers.",
"status": "complete",
"value": {
"amount": 60590640,
"currency": "GBP"
},
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Supply Chain",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s)."
}
},
{
"id": "2",
"title": "Infliximab",
"description": "This Lot is for the supply Infliximab 100mg powder for concentrate for solution for infusion to NHS Scotland. This Lot has been awarded as an unranked multi supplier Framework and awarded to five (5) suppliers.",
"status": "complete",
"value": {
"amount": 29885322,
"currency": "GBP"
},
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Supply Chain",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s)."
}
},
{
"id": "3",
"title": "Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device",
"description": "This Lot is for the supply of Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. The Authority has awarded as an unranked multi-supplier Framework Agreement for the Lot to two (2) suppliers.",
"status": "complete",
"value": {
"amount": 16116574,
"currency": "GBP"
},
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Supply Chain",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "The Authority is entitled at its sole discretion to extend the Framework Agreement of up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s)."
}
},
{
"id": "4",
"title": "Methotrexate (25 mg per 1 ml concentration ) pre-filled syringes",
"description": "This Lot is for the supply of Methotrexate (25 mg per 1 ml concentration ) pre-filled syringes to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. The Authority has awarded a an unranked multi-supplier Framework Agreement for the Lot and to one (1) supplier.",
"status": "complete",
"value": {
"amount": 210740,
"currency": "GBP"
},
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Supply Chain",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "The Authority is entitled at its sole discretion to extend the Framework Agreement of up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s)."
}
},
{
"id": "5",
"title": "Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device",
"description": "This Lot is for the supply of Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. The Authority has awarded a an unranked multi-supplier Framework Agreement for the Lot and to one (1) supplier.",
"status": "complete",
"value": {
"amount": 163880,
"currency": "GBP"
},
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Supply Chain",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "The Authority is entitled at its sole discretion to extend the Framework Agreement of up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s)."
}
}
],
"lotDetails": {
"maximumLotsBidPerSupplier": 2147483647
},
"bidOpening": {
"date": "2018-10-24T12:00:00Z"
},
"contractTerms": {
"hasElectronicPayment": true,
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed"
},
"coveredBy": [
"GPA"
],
"selectionCriteria": {
"criteria": [
{
"type": "suitability",
"description": "Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015"
},
{
"type": "technical",
"description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Goods for the start date of the Framework Agreement. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c)All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design.",
"minimum": "(a) Confirmation that a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Goods will be in place for the start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under Technical and Professional ability: Quality Assurance Schemes. (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products."
}
]
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"techniques": {
"hasFrameworkAgreement": true
},
"classification": {
"id": "33600000",
"scheme": "CPV"
},
"reviewDetails": "The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
"hasRecurrence": false,
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"amendments": [
{
"id": "amd-7",
"description": "Error in closing date of the tender, now changed to reflect correct date of 25/10/2018.",
"unstructuredChanges": [
{
"oldValue": {
"date": "2018-10-24T12:00:00Z"
},
"newValue": {
"date": "2018-10-25T12:00:00Z"
},
"where": {
"section": "IV.2.2",
"label": "Time limit"
}
},
{
"oldValue": {
"date": "2018-10-24T12:00:00Z"
},
"newValue": {
"date": "2018-10-25T12:00:00Z"
},
"where": {
"section": "IV.2.7",
"label": "Conditions for opening of tenders"
}
}
]
}
]
},
"language": "EN",
"description": "The estimated values referred to in each Lot in section II.I.7 and V.2.4 covers the initial twenty four (24) month duration and the maximum twenty four (24) month extension period. (SC Ref:567239)",
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000557325"
},
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000557325"
},
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000557325"
}
],
"noticetype": "OJEU - F3 - Contract Award Notice",
"awards": [
{
"id": "NP47918-1",
"title": "Etanercept",
"suppliers": [
{
"id": "org-183",
"name": "Biogen Idec Ltd."
},
{
"id": "org-184",
"name": "Pfizer Ltd"
},
{
"id": "org-185",
"name": "Sandoz Ltd"
}
],
"relatedLots": [
"1"
]
},
{
"id": "NP47918-2",
"title": "Infliximab",
"suppliers": [
{
"id": "org-183",
"name": "Biogen Idec Ltd."
},
{
"id": "org-185",
"name": "Sandoz Ltd"
},
{
"id": "org-186",
"name": "Napp Pharmaceuticals"
},
{
"id": "org-184",
"name": "Pfizer Ltd"
},
{
"id": "org-187",
"name": "MSD"
}
],
"relatedLots": [
"2"
]
},
{
"id": "NP47918-3",
"title": "Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device",
"suppliers": [
{
"id": "org-188",
"name": "Accord Healthcare Ltd"
},
{
"id": "org-189",
"name": "medac Pharma LLP"
}
],
"relatedLots": [
"3"
]
},
{
"id": "NP47918-4",
"title": "Methotrexate (25 mg per 1 ml concentration ) pre-filled syringes",
"suppliers": [
{
"id": "org-190",
"name": "Nordic Pharma Ltd"
}
],
"relatedLots": [
"4"
]
},
{
"id": "NP47918-5",
"title": "Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device",
"suppliers": [
{
"id": "org-190",
"name": "Nordic Pharma Ltd"
}
],
"relatedLots": [
"5"
]
}
],
"contracts": [
{
"id": "NP47918-1",
"awardID": "NP47918-1",
"title": "Etanercept",
"status": "active",
"value": {
"amount": 49334996,
"currency": "GBP"
},
"dateSigned": "2018-11-19T00:00:00Z"
},
{
"id": "NP47918-2",
"awardID": "NP47918-2",
"title": "Infliximab",
"status": "active",
"value": {
"amount": 24491539,
"currency": "GBP"
},
"dateSigned": "2018-11-19T00:00:00Z"
},
{
"id": "NP47918-3",
"awardID": "NP47918-3",
"title": "Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device",
"status": "active",
"value": {
"amount": 15170847,
"currency": "GBP"
},
"dateSigned": "2018-11-19T00:00:00Z"
},
{
"id": "NP47918-4",
"awardID": "NP47918-4",
"title": "Methotrexate (25 mg per 1 ml concentration ) pre-filled syringes",
"status": "active",
"value": {
"amount": 414634,
"currency": "GBP"
},
"dateSigned": "2018-11-19T00:00:00Z"
},
{
"id": "NP47918-5",
"awardID": "NP47918-5",
"title": "Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device",
"status": "active",
"value": {
"amount": 323948,
"currency": "GBP"
},
"dateSigned": "2018-11-19T00:00:00Z"
}
],
"relatedProcesses": [
{
"id": "1",
"relationship": [
"planning"
],
"scheme": "EU-OJ",
"identifier": "2018/S 183-413669"
}
],
"bids": {
"statistics": [
{
"id": "256",
"measure": "bids",
"value": 3,
"relatedLot": "1"
},
{
"id": "257",
"measure": "bids",
"value": 5,
"relatedLot": "2"
},
{
"id": "258",
"measure": "bids",
"value": 2,
"relatedLot": "3"
},
{
"id": "259",
"measure": "bids",
"value": 1,
"relatedLot": "4"
},
{
"id": "260",
"measure": "bids",
"value": 1,
"relatedLot": "5"
}
]
}
}